Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
As of April 6, 2026, Evogene Ltd Ordinary Shares (EVGN) trades at $0.78, marking a minor 0.15% decline in the current session. This analysis evaluates recent trading trends, key technical levels, and potential near-term scenarios for the biotech stock, with no investment recommendations included. No recent earnings data is available for EVGN at the time of writing, so price action in recent weeks has been driven primarily by broader market sentiment and sector flows rather than company-specific
Is Evogene (EVGN) Stock a Safe Investment | Price at $0.78, Down 0.15% - Profit Potential
EVGN - Stock Analysis
4332 Comments
1221 Likes
1
Christorpher
Elite Member
2 hours ago
Execution like this inspires confidence.
👍 110
Reply
2
Kimura
Influential Reader
5 hours ago
I would watch a whole movie about this.
👍 15
Reply
3
Othoniel
Engaged Reader
1 day ago
I should’ve waited a bit longer before deciding.
👍 91
Reply
4
Tani
New Visitor
1 day ago
Are you secretly training with ninjas? 🥷
👍 14
Reply
5
Kaiceon
Registered User
2 days ago
I need sunglasses for all this brilliance. 🕶️
👍 169
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.